Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 1,908.00
0.00 (0.00%)
Jul 28, 2026, 4:59 PM CET
Genmab Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,901 | 3,720 | 3,121 | 2,390 | 2,084 | 1,287 |
Revenue Growth | 20.66% | 19.19% | 30.59% | 14.68% | 61.88% | -22.52% |
Gross Profit Gross Profit Growth | 3,640 | 3,482 | 2,978 | 2,357 | 2,084 | 1,287 |
Operating Income Operating Income Growth | 1,287 | 1,250 | 1,015 | 772 | 900.43 | 451.68 |
Net Income Net Income Growth | 821 | 963 | 1,133 | 631 | 783.33 | 452.29 |
Earnings Per Share EPS Growth | 13.11 | 15.37 | 17.53 | 9.58 | 11.87 | 6.85 |
EPS Growth | -25.81% | -12.32% | 82.98% | -19.27% | 73.29% | -42.30% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
DARZALEX Royalties DARZALEX Royalties Growth | 2,443 | 2,443 | 2,019 | 1,635 | 1,435 | 928.52 |
Kesimpta Royalties Kesimpta Royalties Growth | 443 | 443 | 323 | 217 | 112.15 | 35.95 |
TEPEZZA Royalties TEPEZZA Royalties Growth | 105 | 105 | 106 | 102 | 114.6 | 90.71 |
Other Product Royalties Other Product Royalties Growth | 111 | 111 | 69 | 35 | 5.9 | 2.14 |
Net Product Sales Net Product Sales Growth | 398 | 398 | 253 | 61 | - | - |
Reimbursement Reimbursement Growth | 53 | 53 | 144 | 124 | 117.77 | 81.23 |
Milestone Milestone Growth | 97 | 97 | 145 | 171 | 254.4 | 145.93 |
Collaboration Collaboration Growth | 70 | 70 | 62 | 45 | 47.8 | 3.06 |
Revenue (Total) Revenue (Total) Growth | 3,720 | 3,720 | 3,121 | 2,390 | 2,088 | 1,287 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,525 | 1,715 | 2,954 | 4,171 | 3,207 | 2,958 |
Total Debt Total Debt Growth | 5,351 | 5,426 | 144 | 114 | 85.78 | 65.01 |
Net Cash (Debt) Net Cash Growth | -3,826 | -3,711 | 2,810 | 4,057 | 3,122 | 2,893 |
Net Cash Growth | - | - | -30.74% | 29.96% | 7.91% | 11.69% |
Net Cash Per Share Net Cash Per Share Growth | -61.05 | -59.19 | 43.46 | 61.57 | 47.29 | 43.80 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 902 | 1,186 | 1,126 | 1,071 | 562.07 | 340.79 |
Capital Expenditures CapEx Growth | -30 | -37 | -27 | -53 | -45.55 | -38.55 |
Free Cash Flow Free Cash Flow Growth | 872 | 1,149 | 1,099 | 1,018 | 516.52 | 302.24 |
Free Cash Flow Growth | -24.76% | 4.55% | 7.96% | 97.09% | 70.90% | -69.98% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 93.31% | 93.60% | 95.42% | 98.62% | 100.00% | 100.00% |
Operating Margin | 32.99% | 33.60% | 32.52% | 32.30% | 43.21% | 35.08% |
Pretax Margin | 26.51% | 32.37% | 42.49% | 34.18% | 47.88% | 46.55% |
Profit Margin | 21.05% | 25.89% | 36.30% | 26.40% | 37.59% | 35.13% |
FCF Margin | 22.35% | 30.89% | 35.21% | 42.59% | 24.79% | 23.48% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.45 | 20.38 | 11.62 | 33.03 | 35.26 | 58.19 |
Forward PE | 22.92 | 20.23 | 17.44 | 29.87 | 39.46 | 56.53 |
P/FCF Ratio | 20.72 | 17.08 | 11.98 | 20.47 | 53.47 | 87.08 |
PS Ratio | 4.63 | 5.28 | 4.22 | 8.72 | 13.25 | 20.44 |